Balaji Amines [BALAMINES] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison

Balaji Amines Ltd.

NSE
Loading...

Neogen Chemicals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Balaji Amines Ltd. wins in 16 metrics, Neogen Chemicals Ltd. wins in 4 metrics, with 0 ties. Balaji Amines Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Balaji Amines Ltd. Neogen Chemicals Ltd. Better
P/E Ratio (TTM) 27.48 222.22 Balaji Amines Ltd.
Price-to-Book Ratio 2.11 5.46 Balaji Amines Ltd.
Debt-to-Equity Ratio 1.53 141.47 Balaji Amines Ltd.
PEG Ratio -3.75 -3.52 Neogen Chemicals Ltd.
EV/EBITDA 17.48 42.55 Balaji Amines Ltd.
Profit Margin (TTM) 10.42% 2.41% Balaji Amines Ltd.
Operating Margin (TTM) 12.83% 11.39% Balaji Amines Ltd.
EBITDA Margin (TTM) 12.83% 11.39% Balaji Amines Ltd.
Return on Equity 7.80% 4.41% Balaji Amines Ltd.
Return on Assets (TTM) 6.99% 1.99% Balaji Amines Ltd.
Free Cash Flow (TTM) $685.60M $-1.22B Balaji Amines Ltd.
Dividend Yield 0.65% 0.19% Balaji Amines Ltd.
1-Year Return 46.74% 22.53% Balaji Amines Ltd.
Price-to-Sales Ratio (TTM) 2.87 5.56 Balaji Amines Ltd.
Enterprise Value $40.05B $53.55B Neogen Chemicals Ltd.
EV/Revenue Ratio 2.90 6.55 Balaji Amines Ltd.
Gross Profit Margin (TTM) 44.53% 47.11% Neogen Chemicals Ltd.
Revenue per Share (TTM) $427 $310 Balaji Amines Ltd.
Earnings per Share (Diluted) $44.52 $7.47 Balaji Amines Ltd.
Beta (Stock Volatility) 0.44 0.22 Neogen Chemicals Ltd.

Balaji Amines Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

BALAMINES
NEOGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Balaji Amines Ltd.-1.17%0.82%23.56%108.04%87.19%89.97%
Neogen Chemicals Ltd.1.51%8.10%24.00%48.67%91.41%75.54%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Balaji Amines Ltd.46.74%-5.67%-17.19%754.74%5,397.42%7,405.28%
Neogen Chemicals Ltd.22.53%26.54%147.06%676.07%676.07%676.07%

Performance & Financial Health Analysis: Balaji Amines Ltd. vs Neogen Chemicals Ltd.

MetricBALAMINESNEOGEN
Market Information
Market Cap i₹40.18B₹44.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i100,986170,744
90 Day Avg. Volume i115,396127,390
Last Close₹2,108.10₹2,064.40
52 Week Range₹968.10 - ₹2,262.50₹966.70 - ₹2,087.30
% from 52W High-6.82%-1.10%
All-Time High₹5,223.55 (Sep 13, 2021)₹2,420.00 (Dec 09, 2024)
% from All-Time High-59.64%-14.69%
Growth Metrics
Quarterly Revenue Growth0.06%0.09%
Quarterly Earnings Growth-0.05%-0.63%
Financial Health
Profit Margin (TTM) i0.10%0.02%
Operating Margin (TTM) i0.13%0.11%
Return on Equity (TTM) i0.08%0.04%
Debt to Equity (MRQ) i1.53141.47
Cash & Liquidity
Book Value per Share (MRQ)₹581.05₹303.78
Cash per Share (MRQ)₹56.18₹57.58
Operating Cash Flow (TTM) i₹2.65B₹645.50M
Levered Free Cash Flow (TTM) i₹1.58B₹348.30M
Dividends
Last 12-Month Dividend Yield i0.65%0.19%
Last 12-Month Dividend i₹11.00₹3.00

Valuation & Enterprise Metrics Analysis: Balaji Amines Ltd. vs Neogen Chemicals Ltd.

MetricBALAMINES (Apr 24, 2026)NEOGEN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i27.48222.22
Forward P/E i18.9172.26
PEG Ratio i-3.75-3.52
Price to Sales (TTM) i2.875.56
Price to Book (MRQ) i2.115.46
Market Capitalization
Market Capitalization i₹40.18B₹44.76B
Enterprise Value i₹40.05B₹53.55B
Enterprise Value Metrics
Enterprise to Revenue i2.906.55
Enterprise to EBITDA i17.4842.55
Risk & Other Metrics
Beta i0.440.22
Book Value per Share (MRQ) i₹581.05₹303.78

Financial Statements Comparison: Balaji Amines Ltd. vs Neogen Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBALAMINES (2025)NEOGEN (2025)
Revenue/Sales i13.86B7.58B
Cost of Goods Sold i7.94B4.44B
COGS % of Revenue i57.3%58.6%
Gross Profit i5.91B3.13B
Gross Margin i42.7%41.4%
Research & Development i7.84M11.50M
Operating Income (EBIT) i1.84B1.09B
Operating Margin i13.3%14.4%
EBITDA i2.63B1.31B
EBITDA Margin i19.0%17.3%
Pre-Tax Income i2.13B501.60M
Pre-Tax Income % of Revenue i15.4%6.6%
Income Tax i546.28M153.30M
Income Tax % of Revenue i3.9%2.0%
Net Income (Profit) i1.59B348.30M
Profit Margin i11.4%4.6%

Balance Sheet & Liquidity Metrics

MetricBALAMINES (2025)NEOGEN (2025)
Cash & Equivalents i1.49B49.60M
Total Current Assets i9.41B10.00B
Total Current Assets % of Revenue i67.9%132.0%
Total Current Liabilities i1.30B7.33B
Total Current Liabilities % of Revenue i9.4%96.8%
Long-Term Debt i18.83M1.94B
Long-Term Debt % of Revenue i0.1%25.6%
Total Shareholders Equity i20.18B7.89B
Retained Earnings i16.46B2.28B
Retained Earnings % of Revenue i118.8%30.1%
Property, Plant & Equipment i4.14M890.30M

Cash Flow Statement Comparison

MetricBALAMINES (2025)NEOGEN (2025)
Operating Cash Flow i2.65B645.50M
Operating Cash Flow % of Revenue i19.1%8.5%
Capital Expenditures i-1.86B-3.17B
Free Cash Flow i685.60M-1.22B
FCF Margin i4.9%-16.1%
Debt Repayment i-90.91M-718.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBALAMINESNEOGEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i32.40M27.38M
Float Shares i10.31M13.28M
% Held by Insiders i67.63%53.98%
% Held by Institutions i2.21%23.81%
% Held by Public i30.16%22.21%

Dividend Analysis & Yield Comparison: Balaji Amines Ltd. vs Neogen Chemicals Ltd.

MetricBALAMINESNEOGEN
Last 12-Month Dividend i₹11.00₹3.00
Last 12-Month Dividend Yield i0.65%0.19%
3-Year Avg Annual Dividend i₹10.67₹2.00
3-Year Avg Dividend Yield i0.51%0.11%
3-Year Total Dividends i₹32.00₹6.00
Ex-Dividend DateAug 01, 2025Sep 19, 2025